We performed a test sample study to try to identify errors leading to irreproducibility, including incompleteness of peptide sampling, in liquid chromatography-mass spectrometry-based proteomics. We distributed an equimolar test sample, comprising 20 highly purified recombinant human proteins, to 27 laboratories. Each protein contained one or more unique tryptic peptides of 1,250 Da to test for ion selection and sampling in the mass spectrometer. Of the 27 labs, members of only 7 labs initially reported all 20 proteins correctly, and members of only 1 lab reported all tryptic peptides of 1,250 Da. Centralized analysis of the raw data, however, revealed that all 20 proteins and most of the 1,250 Da peptides had been detected in all 27 labs. Our centralized analysis determined missed identifications (false negatives), environmental contamination, database matching and curation of protein identifications as sources of problems. Improved search engines and databases are needed for mass spectrometry-based proteomics.
Liquid chromatography-mass spectrometry (LC-MS) has become the most popular technique for proteomics analysis. In this strategy, proteins of a sample are typically separated by PAGE and then digested with trypsin. After extraction from the gel, peptides are separated by liquid chromatography and upon elution are ionized via electrospray into the mass spectrometer for characterization by mass analysis. The mass spectrometer subsequently selects peptides for fragmentation to yield mass values that are then used to identify the peptide and the corresponding protein by searching sequence databases. This technique, termed tandem mass spectrometry (MS), is repeated to continuously select ionized peptides from the liquid chromatography column. Depending on protein abundance and complexity, the mass spectrometer type and its setup, up to about 15,000 peptides and up to about 4,000 proteins can be identified in a single experiment 1 .
Despite the high mass accuracy of modern mass spectrometers, the general perception of the reliability of MS-based proteomics is that it is low. Previous test sample studies have demonstrated that there is both a lack of reproducibility between different laboratories as well as a general inability to identify purified proteins in samples of low complexity 2 (http://www.abrf.org/Research Groups/ProteomicsStandardsResearchGroup/EPosters/ABRFsPRG Study2006poster.pdf). This is in part due to the stochastic nature of peptide sampling by the mass spectrometer and the inherent bias toward peptides of higher concentrations, which also confounds the statistical challenges and pitfalls associated with MS-based analyses, particularly when samples are rich in protein complexity. Protein solubilization, protein separation, protease digestion, peptide separation and peptide selection, all involve steps and protocols that vary greatly among labs, and different commercially available tandem mass spectrometers have different mass accuracies and different rates of peptide selection for fragmentation. The use of different search engines to decode tandem mass spectra and match them to databases of theoretical tryptic peptides is also a source of variability 3 , because of differences in the search engines themselves as well as different false discovery rates 4, 5 . Furthermore, the matching of high-quality tandem mass spectra to different databases may lead to irreproducibility as protein databases vary greatly in terms of their curation, completeness and comprehensiveness [6] [7] [8] . Despite variability in instruments, search engines and databases, the high mass accuracy of modern mass spectrometers 9 should assure a 100% success rate of protein identification for those tryptic peptides that readily ionize and for which high-quality tandem mass spectra can be obtained.
Prior work in analytical chemistry and genomics [10] [11] [12] [13] [14] has demonstrated the benefits of standardized test sample efforts for testing the reproducibility of technology platforms. To address the question of reproducibility in LC-MS-based proteomics 15 , the Human Proteome Organization (HUPO) created a test sample working group to carry out a controlled study involving 27 different labs. We produced a test sample made up of 20 human proteins of high purity and at equimolar ratios. To test for any potential stochastic bottleneck as a consequence of current data-dependent acquisition methods 16 , all 20 proteins were selected to contain at least one unique tryptic peptide of 1,250 ± 5 Da each with a different amino acid sequence. The primary task given to members of the 27 labs was to identify all 20 human proteins and all unique peptides (22) of mass 1,250 ± 5 Da and to report these to the lead investigator, A.W.B. We encouraged members of the labs to use whatever optimized procedures and instrumentation they routinely used, without constraints, which would allow us to assess any trends in those procedures or instruments that were the most effective. We had the labs use the same version of the National Center for Biotechnology Information (NCBI) nr human protein database (27 November 2006 ) so as to minimize variability in data matching and reporting.
For the first time, to our knowledge, in a proteomics test sample study, each of the participating laboratories is publicly identified here, though all data have been rendered anonymous to prevent tracking to any individual lab. This test sample experiment goes beyond previous efforts as after the findings from these the 27 labs were initially reported to us, we communicated back to them the potential sources of misidentification such that most errors could be corrected. Furthermore, we requested that members of each lab deposit all raw data, methodology, peak lists, peptide statistics and protein identifications into Tranche 17 for subsequent submission to the Proteomics Identifications Database (PRIDE) 18 . The availability of the raw data allowed us to centrally analyze all data. This analysis showed that even though members of most participating labs initially did not report all 20 proteins and the 22 1,250-Da peptides correctly, their raw data clearly indicated that most participants should have been able to identify all 20 proteins as well as most of the 22 1,250-Da peptides.
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RESULTS

Test sample proteins
To create the test sample, we selected 20 proteins in the molecular weight range of 32-110 kDa from the open reading frame (ORF) 19 collection and the mammalian gene collection 20 (Supplementary Methods online). The criteria ( Supplementary Fig. 1a online) for selection included a purity of about 95%, unique tryptic peptide sequences and the presence of at least one tryptic peptide of 1,250 ± 5 Da ( Supplementary Fig. 1b,c) . We expressed the candidate proteins in Escherichia coli and purified them following a production strategy by using ion exchange and reverse phase chromatography or by preparative electrophoresis purification from inclusion bodies (Supplementary Methods). One-dimensional SDS-PAGE revealed the purity of the 20 purified proteins (Supplementary Fig. 1d ) at 95% or greater (Supplementary Table 1 online) as evaluated by densitometry ( Supplementary Fig. 2 and Supplementary Table 2 online). MS analysis of the 20 purified proteins revealed a vector-derived N-terminal extension of 7 amino acids present on each of the proteins ( Supplementary Fig. 3 online). MS analysis of the test sample confirmed quality (Supplementary Fig. 4 and Supplementary Tables 2,3 online) and stability (Supplementary Fig. 5 and Supplementary Table 4 online) before distribution to the 27 labs.
Protein identification
We instructed members of the 27 selected labs to use the NCBI nr human protein database of November 27, 2006 with exact matches for all 20 test sample proteins ( Supplementary Fig. 6 and Supplementary Table 5 online) for protein identification. The individual results from the labs are reported in Supplementary Table 6 online © 2009 Nature America, Inc. All rights reserved. Initial and final reporting of the number of peptides of mass 1,250 ± 5 Da with increases in totals related to tabulation of mass-shifted cysteine-containing peptides. + indicates a correct identification. Analysis scoring was calculated from the fraction of correct peptide identifications and the accuracy of reporting peptides of mass 1,250 Da, whereas the report scoring was based on the fraction of correct peptide identifications reported divided by the number identified by the centralized analysis. Results not reported, NR; no raw data, NRD; submitted and data reprocessing difference, DRD. DRDs are indicated by fewer peptides identified by the centralized analysis as compared to the number reported. Positive identifications included cysteine-containing peptides that have been alkylated, peptides including missed trypsin cleavage and oxidized methionine residues. Labs A, 4-9, 11 and 13 reported peptides assigned at o95% confidence. Lab 6 used iTRAQ. and are summarized in Table 1 . Analysis of the reports revealed clear differences in the number of tandem MS spectra assigned based on the instrument used ( Supplementary Fig. 7 online) but incorrect reporting of false positive and contaminating proteins were not specifically linked to any MS platform or search engine. Initially, members of only 7 labs (classified as group I) correctly identified all 20 proteins ( Table 1 ). The labs classified as group II encountered naming errors. Labs classified as group III encountered naming errors, false positive and redundant identifications ( Supplementary Fig. 8 and Supplementary Table 7 online). No redundant identifications were reported by members of any lab that used the Mascot (Matrix Science) search engine (n ¼ 11) whereas labs using Sequest and SpectrumMill did report redundant identifications. Labs classified as group IV encountered several problems. We distributed another aliquot of the sample to labs that indicated trypsinization problems (labs C, 23 and 24; Supplementary Table 8 online). Members of lab 22, who had a problem with undersampling, ( Supplementary Table 9 online) performed an additional analysis with their remaining sample. Other errors encountered by group IV included incomplete matching of tandem MS spectra resulting from acrylamide alkylation ( Supplementary Fig. 9 online), database search errors ( Supplementary  Table 10 online) and the use of overly stringent identification criteria (Supplementary Table 11 online), all of which resulted in missed identifications. We devised a scoring system to take incorrect reporting into account. After we discussed the problems with members of each laboratory (Supplementary Table 12 online) and in some cases had them perform repeat analyses, all identified all 20 proteins, achieving a uniform score of 100% (data not shown).
Peptide sampling
We also assessed the completeness of peptide sampling and selection in the mass spectrometer by assessing the ability of the 27 labs to detect the 22 designed tryptic peptides of mass 1,250 ± 5 Da (Supplementary Table 13 online), six of which contained cysteine residues whose mass increased as a consequence of reduction and alkylation as routinely used before protein trypsinization. Initially, members of only one lab (lab 14) reported detection of all 22 peptides ( Table 2 ) and only an additional three groups (labs 17, B and CR; R indicates repeat analysis) reported detecting any peptides that contained cysteines. Several groups incorrectly reported peptides of 1,250 ± 5 Da derived from contaminating proteins. Several groups also reported peptides of 1,250 ± 5 Da as a result of a single missed trypsin cleavage (denoted as a true positive). We requested that these labs perform a reassessment as described above for protein reporting. We used our scoring system to assess both the analysis and the reporting of the 1,250 ± 5 Da tryptic peptides. Initially, only members of lab 14 achieved a 100% score. After guidance, members of lab 3 achieved 100% success by correcting for cysteine-containing peptides and excluding peptides derived from contaminants. All other groups reported insufficient data. To distinguish between incomplete reporting and incomplete sampling, we compared the 1,250-Da peptides that were reported to those that were identified by the centralized analysis (see below). Results from labs 10, 11, 14 and 18 (but not lab 3) had data for all 22 1,250-Da peptides. However, members of labs 10, 11 and 18 could not report the peptides and our centralized analysis failed to identify the 22 peptides in the data from lab 3 ( Table 2) . Besides lab 14, only lab 7 achieved 100% reporting of all 1,250-Da peptides in their dataset (a total of 19 peptides, as assessed by our centralized analysis of the data) ( Table 2 and Supplementary Table 13 ).
Data deposition to Tranche and PRIDE
We asked members of the 27 labs to transfer their raw MS data, the methodologies used, peak lists, peptide statistics and protein identifications to Tranche, a repository for raw data. Initial problems related to the transfer of data to Tranche were all overcome. Tranche hash and passphrase codes are available in Supplementary  Table 14 online. PRIDE personnel transferred a copy of all data from Tranche to PRIDE, a centralized public data repository for the standardized reporting of proteomics results. As evaluated by PRIDE personnel, the initially deposited data had several problems including incomplete files, proprietary software formats and screenshots of data displays in software rather than actual data files. The wide variety of data formats encountered faithfully represents the heterogeneity in the field concerning proteomics bioinformatics. It also appears that the implementation of community standards for data reporting and exchange is not yet at a level that accommodated the minimal requirements for these 20 test proteins.
Centralized analysis of the raw data
To independently assess the individual analyses of the 27 labs, we downloaded all raw data from Tranche. We reanalyzed the collective raw data centrally using a uniform protocol of database searching using X! Tandem 21 and post-processing with the Trans Proteomic Pipeline 22 to assign probabilities to all identifications and global false discovery rates as well as to determine the total number of tandem MS spectra assigned, number of distinct peptides and amino acid sequence coverage (Supplementary Tables 13 and 15 online).
We found that members of the majority of the labs had in fact generated raw data of sufficient quality to identify all 20 proteins and most of the 22 1,250-Da peptides. We identified discrepancies between the submitted results ( Supplementary Table 12 ) and the centrally reprocessed results ( Supplementary Table 15 ) for labs 2, 4, 5, 8, 10, 11, 16, 19, 20, 21, 22R, 24 and CR, largely owing to the different data analysis strategies used in these labs. The centralized analysis included checks for experimental artifacts including pyro-Glu formation, deamidations and nontryptic cleavages.
For all 27 labs, the majority of tandem mass spectra (79%) were assigned to the 20 recombinant human proteins, but 21% of the spectra were assigned to contaminants that included E. coli proteins, trypsin, keratins and other proteins ( Fig. 1a and Supplementary Table 15 ). The centralized analysis also revealed that all 22 predicted tryptic peptides of 1,250 Da were observed in only 4 labs, three of which used a Fourier transform ion cyclotron resonance (FTICR) instrument (Tables 1 and 2) . These instruments reported the highest number of assigned tandem mass spectra, thereby increasing the likelihood of identifying all of the 1,250-Da peptides ( Supplementary Fig. 7) . Tandem mass spectra matching the 1,250-Da peptides were variable for each of the 20 proteins ( Fig. 1b) and were variably detected in our centralized analysis ( Supplementary Fig. 10 online) .
The centralized analysis also revealed (i) that the majority of tandem MS spectra assigned to keratins (human keratins KRT1, KRT2, KRT9 and KRT10 are commonly found in mature epidermal tissue and are also present in laboratory dust and fingerprints, rather than hair-or wool-derived keratins) were largely attributed to strategies that used one-dimensional PAGE ( Supplementary  Fig. 11 and Supplementary Table 15 online); (ii) that E. coli proteins were found by members of all but 2 labs ( Supplementary  Fig. 11 and Supplementary Table 15 ) and most likely were present in the provided sample; (iii) that other protein contaminants (for example, albumin and casein) were found in datasets from a specific subset of labs (5 labs found albumin, 5 casein and 3 both proteins; albumin was incorrectly reported as human when in fact it was bovine, and both bovine serum albumin and casein are likely abundant proteins used in these labs for standardization); and (iv) that autolytic trypsin peptides resulted from added trypsin. Excluding the contaminants introduced in the labs, 94% of the tandem mass spectra were accounted for by the 20 recombinant proteins, and the remaining tandem MS spectra were assigned to the E. coli proteins (Fig. 1a) . False negatives (one or more of the 20 recombinant proteins not detected) were likely a consequence of variability in trypsin digestion and the stochastic sampling of the mass spectrometry analysis.
Labs that used exclusively liquid phase separations in general had fewer spectra that could be assigned to epidermal keratins than labs that used a combination of protein separation by gel electrophoresis followed by in-gel digestion, peptide extraction and highperformance liquid chromatography peptide separation before tandem MS analysis ( Supplementary Fig. 11 ). This trend is probably caused by the fact that each gel slice was exposed to the environment individually, effectively increasing the load of environmental contaminants. The number of spectra that could be assigned to keratins was also broadly correlated with the identification of low-concentration sample source contaminants (E. coli proteins) and reagent proteins (trypsin), suggesting that in most cases these proteins were present at substantially lower concentrations than the 20 test sample proteins ( Supplementary Table 15 ).
Our centralized analysis confirmed that raw data initially reported by members of 4 labs were incomplete ( Supplementary  Table 15 ). Repeat analysis in these labs generated sufficient data to © 2009 Nature America, Inc. All rights reserved. identify the 20 proteins. No tandem mass spectra were initially observed for the ATAF2 protein in labs 24 and C (Fig. 2) , but in a repeat analysis, they generated sufficient tandem mass spectra (marked as 24R and CR) to characterize the protein as well as the 1,250-Da peptide. However, members of labs 19, 20 and 21 generated sufficient tandem mass spectra for protein ATPAF2, members of lab 20 generated sufficient tandem mass spectra for protein SETD3, and members of labs 19 and C generated sufficient tandem mass spectra for protein F2 but still did not initially report the identification of these proteins. We determined that members of lab 20 had a database-matching problem for protein SETD3 and members of lab 19 had an acrylamide modification problem for protein F2. Lab 24 had a trypsinization problem for protein F2, which was fixed upon repeat analysis (24R). Although lab C initially reported a trypsinization problem for the F2 protein, the raw data proved otherwise. Lab C's repeat analysis (CR) revealed more tandem mass spectra assigned to protein F2 but insufficient data for the peptide of mass 1,250 Da. Detailed central analysis of each lab's data submitted to Tranche justified the removal of results from lab 24 (but not of this lab's repeat analysis, 24R) from the heat map shown in Figure 1b . Inspection of the results from lab 24 (Supplementary Table 13 ) revealed that B95% of the tandem mass spectra were assigned to peptides with cyclized N-terminal glutamine amino acid (pyroGln), which is not typical for analysis of tryptic peptides. Additional in-depth analysis of the raw data did not identify tandem mass spectra; aberrant chemically induced modifications may have been introduced.
DISCUSSION
Our results demonstrate that, of 27 labs, members of only 7 labs initially characterized an equimolar sample of 20 human proteins. However, our centralized analysis of the raw data demonstrated that members of each of the labs, with a few exceptions, had in fact generated mass spectrometry data of very high quality, more than sufficient to identify all 20 proteins and most of the 22 1,250-Da peptides. This demonstrates the important need for education and training to properly apply such a complex technology. Most notably, we found generic problems in databases to be the major hurdle for the correct characterization of proteins in the test sample. The search engines used in this study at present cannot distinguish among different identifiers for the same protein, deriving from the way the databases are constructed. Indeed, the search engines used either for the centralized data analysis or by the individual labs suggest an erroneous confidence to the assignments of peptides and proteins. This erroneous confidence necessitates the use of manual verification of both the peptide assignments and protein assignments for low-confidence identifications.
An extended standardized FASTA format (http://psidev.info/ index.php?q¼node/317) has been proposed by HUPO Proteomics Standards Initiative (PSI) that would resolve the problem of standardized annotation. Presently, manual curation of tandem MS data search results is needed for correct reporting. This includes the nonredundant assignments of tandem MS spectra to overcome the common errors in the apparent characterization of different proteins that are one and the same. We have observed that algorithms used by different search engines to calculate molecular weight are variable (data not shown). It is therefore reasonable to suggest that a common method for calculating molecular weight be chosen and used throughout the community. Additionally, the automatic matching of tandem mass spectra of high quality to a protein-coding genome with a single representative protein for each gene could overcome several of the current errors in protein naming and redundancies.
A test sample containing 20 proteins at 5 pmol equimolar abundance is not representative of a proteomics study with complex mixtures. However, a routine 100% success rate of protein and 1,250-Da peptide identification of such a test sample could be implemented as a standard, as well as the routine deposition of raw data into Tranche. This would enable a greater degree of trust in the conclusions deduced for proteomics studies in general. A limited number of the 20 test sample protein mixtures have been prepared and are available by contacting the lead author (A.W.B.). These samples, however, are stored in 7.5 M urea, which leads to variable carbamylation, and this may affect trypsinization as well as data analysis. Such test samples should be helpful as a benchmarking tool for researchers embarking on a proteomics study with complex mixtures. At the least, their abilities to collect sufficient data for unambiguous identification of 20 human proteins and 22 1,250-Da peptides can be assessed. A peptide-by-peptide comparison of results from any individual lab with those from a centralized analysis of the data should be informative to the inability of any lab's members to detect proteins or specific peptides. For any large-scale, multilab proteomics effort, we recommend the use of a centralized analysis, especially if data are generated on more than one platform, generated in more than one location or collected over time.
Our study allowed us to deduce several guidelines for performing any proteomics experiment. Sources of lab-derived contamination need to be identified and monitored closely, with the two major sources being environmental contamination carried over from prior experiments and keratins (largely from gel-based analysis). The use of target-decoy search strategies should be made mandatory, and false discovery rates should be reported. The monitoring of unique peptides and unique tandem mass spectra is needed to ensure that the minimum list of protein identifications is reported, to address the issue of redundant identifications (sequence variants of the same protein). A gene-centric database could ensure that only a single descriptive name would be assigned to each protein sequence, eliminating aliases. The creation of tools for transforming data (raw data, peak lists, peptide lists and protein lists) into standardized formats would aid the ease of submission to repositories such as Tranche. The distribution of all data deposited in Tranche to the community, via PRIDE, Human ProteinPedia, PeptideAtlas and GPM, would facilitate centralized data analysis which may help lead to new insights in proteomics experiments.
In summary, our analysis showed that even with a sample consisting of highly purified human proteins, members of many participating labs had difficulties in reporting data correctly. However, the majority of the participants deposited raw data, each with more than sufficient coverage of the 20 proteins. Thus a major contributing factor to erroneous reporting resides at the level of database and search engines used and once corrected for, provided an almost perfect score for most participants. Therefore, we expect that once databases and search engines have been improved and made compatible with MS-based proteomics, the accuracy of data reporting will increase and along with it, the fidelity of proteomics.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/.
Note: Supplementary information is available on the Nature Methods website.
ONLINE METHODS
Test sample generation and distribution. As more completely described in the Supplementary Methods, all test sample proteins were cloned 23 and expressed 24 in E. coli, purified from inclusion bodies under denaturing conditions and mixed in equimolar (5 pmol) amounts. A committee made up of funding agency representatives (NIH and Canadian Institutes of Health Research), journal editors and the HUPO Executive Committee proposed a list of 55 labs. Invitations to participate were extended to 41 labs and 24 accepted. Also, 6 mass spectrometer vendors were selected by the HUPO Industrial Advisory Board (IAB) and all agreed to participate but only 3 provided results. The 27 labs that participated are indicated here as co-authors. Dried samples containing 5 picomoles of each protein were shipped on dry ice, along with detailed examples of LC-MS proteomics analyses (http://www.invitrogen.com/etc/medialib/ en/filelibrary/pdf.Par.72904.File.tmp/HumanProteinStandardsfor MassSpectrometry.pdf). Samples were shipped from Invitrogen and deliveries were overnight (by DHL in the USA and DHL International or FedEx International express overseas; 1 to 3 business day delivery). Delivery to Australia was delayed on two occasions owing to incomplete customs-related documentation that resulted in the samples attaining ambient temperatures and hence their replacement. Another two samples were received at the recipient institutes but did not arrive at the host lab. One vial was reported to be empty as negligible signal was observed by Coomassie blue staining of a two-dimensional gel. In all cases, more material was supplied. Participants were instructed to use a specified NCBI nr database (http://portal. proteomics.mcgill.ca:8080/hupo-standards/nr_human_20061127_ v2.fasta), to report details of methodologies used and proteins identified and to deposit raw data and reports to Tranche (http://tranche.proteomecommons.org/) (Supplementary Note online).
Instructions to laboratories and vendors. Test samples were distributed to participating laboratories, who were instructed to (i) identify the 20 human proteins, (ii) report the details of the identifications (protein name, NCBI gi number, sequence coverage, number of peptides and number of tandem MS spectra) following the criteria of ref. 25 and (iii) report the details of methodology. The following description of the sample was supplied: ''The sample is an equimolar mixture (5 pmol) of 20 human proteins that were expressed in E. coli under conditions to maximize inclusion body formation. The expression system results in an N-terminal extension of 7 amino acids (sequence MYKKAGT) followed by the encoded initiator methionine. The 20 proteins were purified by preparative SDS PAGE or 2D-LC (anion exchange and reversed phase) to 4 95% purity. Trypsin digestion of the purified constructs results in the generation of a tripeptide (MYK) plus free K or a tetrapeptide (MYKK) resulting from 1 missed cleavage and an N-terminal extension of 3 (AGT) or 4 (KAGT, 1 missed cleavage) amino acids. Contaminants do not exceed 1% in the final mixture.'' Details regarding the proteomics MS analysis as well as the selection and purification of the test sample proteins by Invitrogen were also supplied (poster presentation (http://www. invitrogen.com/etc/medialib/en/filelibrary/pdf.Par.72904.File.tmp/ HumanProteinStandardsforMassSpectrometry.pdf) that was presented at the HUPO 5th Annual World Congress).
Protein identification reports were scored based on acceptable names as found in the specified database. For reassessment, each lab was instructed to make corrections based on naming; redundant, false positive and contaminant identifications; and acrylamide alkylation of cysteines. Labs that did not achieve 100% after reassessment were requested to repeat the analysis of another aliquot of the sample.
Reporting of peptides of mass 1,250 ± 5 Da was requested, with reassessment as above, and reports were scored twofold, for analysis and reporting completeness. Previous efforts to benchmark proteomics through test samples have usually allowed participating labs to choose whatever database they felt might be the most appropriate to match their tandem mass spectra. As we have argued elsewhere 6, 26 , most databases are still in a constant flux changing from one release to another. These changes lead to increased variation in data evaluation. Here we compared the predicted amino acid sequence of the 20 test proteins selected as identified above with the NCBI nonredundant database, the Universal Protein Resource (UniProt) and the International Protein Index (IPI) databases ( Supplementary Table) . Comparisons were made by using blastp (http://www.ncbi.nlm.nih.gov/BLAST/). The reciprocal matching (database to ORF and ORF to database) process revealed differences in protein length as well as amino acid substitutions, most of which occurred in the IPI database and are likely to be related to the specific assembly process of the IPI 27 . Longer or shorter sequences in the database indicate extensions or truncations and/or differences in editing (removal of potential introns) the predicted DNA sequences. Amino acid substitutions are indicated by orange and green shading. An exact match is indicated by 100% identity in both directions. From this database assessment only the NCBInr database had all recombinant proteins with their exact matches represented.
Data reporting. The number of proteins reported and number correct are indicated as are the number of false positive (proteins identified by shared peptides) and contaminant (proteins not in the sample) identifications and those proteins identified more than once but reported as separate proteins (redundant). After the initial reporting by members of the 27 labs (numbers and letters are used to identify academic labs and vendors, respectively), one of us (A.W.B.) discussed with members of each lab problems associated with providing nondescriptive names (for example, hypothetical protein, ORF), and also the reporting of redundant identifications, and false positive and contaminating proteins. Problems associated with spurious alkylation of cysteine residues by acrylamide during preparative electrophoresis were also discussed. Participants were requested to reassess search results and to submit updated final reports. A scoring system was devised to take into account incomplete reporting as well as erroneous identifications. The score ( Table 1 ) was calculated as follows: score ¼ fraction identified (number correct / 20) Â accuracy (number correct / number reported) Â 100. For Table 1 , details for the proteomics analyses on a lab-by-lab basis including protein separation, mass spectrometer, peaklist software and database search engine as well as turn-around time (time from the lab receiving the sample until results were submitted by email (average 67 days)) are indicated. All labs used trypsin. Mass spectrometers used included: ion trap (IT); QToF (QT); hybrid (H) including LTQ-FT or LTQ-Orbitrap; and ToFToF (TT). Peaklists were generated by using the following software: Bioworks Browser Table 14 ).
The methodology, the peak lists, the peptide statistics and protein identification data were transferred to Tranche, a repository for raw data. Detailed instructions (Supplementary Note) were provided to each participating lab with regards to the preparation and transferring of supporting data and information to Tranche (http://www.proteomecommons.org/dev/dfs/examples/ hupo-2007/Tranche-HUPO.jsp). All problems in the transfer of data from host labs to Tranche (for example, compact disk and courier transmission, firewall problems, unresponsive servers) were overcome. The transfer of data culminated with the generation of a Tranche hash and passphrase codes that were returned by e-mail to the submitter and to one of us (A.W.B.). The final set of codes is listed in Supplementary Table 14) .
Transfer of peaklists, search results, peptide statistics and protein identification data from Tranche to PRIDE by the PRIDE personnel led to the successful transfer of 29 datasets (accession numbers: 8130-8158). The data can be accessed by these accession numbers or by project name (HUPO test samples) from the 'Browse experiments' portal at PRIDE. The information in PRIDE comprises protein identifications and spectra from all the groups involved, and all the associated metadata.
Centralized analysis of the collective data. To provide an independent assessment of all individual analyses, we reanalyzed all data collectively by using a uniform protocol of searching with X! Tandem 21 and post-processing with the Trans Proteomic Pipeline 22 to assign probabilities to all identifications and global false discovery rates.
Raw data and supporting documentation as deposited by each lab to Tranche were downloaded by using Tranche hash and passphrase codes ( Supplementary Table 14 online). For labs 1-5, 7, 9-14, 15_1, 16-21, 23R, 24, 24R and A, raw mass spectrometer output files were deposited in the native instrument vendor format. These files were transformed into the open XML format mzXML 28 . Labs 6, 8, 15_2, 22R and B did not provide mass spectrometer output files, and in these cases, the text-format peak list files were used in the centralized analysis. For labs C and CR, mzData files were submitted and used for the analysis. Lab A data were acquired in MS e (ref. 29 ) mode that include low energy (MS scans) and high energy (fragmentation scans) scans without peptide ion selection. Standard processing techniques cannot be applied to the output MS e spectra because co-eluting peptide ions are fragmented simultaneously. For the centalized analysis, lab A provided PKL files with time-deconvolved peaklists. These PKL files were converted to mzXML and processed in the same manner as the others. For lab 7, the conversion from vendor format to mzXML did not sum consecutive scans, which would have resulted in approximately twice as many identified spectra. For this reason, the MGF files provided by the lab that already contained summed scans were used for the analysis.
All of the datasets were subjected to a uniform processing and validation to provide a homogeneous analysis environment in an attempt to minimize data processing differences among the groups. The tandem mass spectra were searched against a reference database constructed from a) the human IPI 3.50 protein list (http://www. ebi.ac.uk/IPI/), b) the non-redundant E. coli database distributed by NCI ABCC dated 2008-02-06 (ftp://ftp.ncifcrf.gov/pub/nonredun/), c) the cRAP set of common contaminant proteins from the Global Proteome Machine database (GPMDB) dated 2008-10-01 (http:// www.thegpm.org/cRAP/index.html), d) the 20 recombinant proteins present in the test samples with the vector-derived N-terminal extension of 7 amino acids and e) finally an appended set of decoy proteins derived by scrambling all tryptic peptides in the target sequences described above. A copy of this constructed database is available at http://www.peptideatlas.org/tmp/HsIPI3.50_Ec_cRAP_ 20_TargetDecoy.fasta. The spectra were searched using the X! Tandem search engine 21 with the K-score plugin 30 .
The search parameter files used for each experiment are available in the centalized reanalysis Tranche project file (Supplementary Table 14 online). In general, the search parameters were: 2 allowed missed cleavages, precursor m/z tolerance from À2.1 to +4.1, fragment m/z tolerance 0.4. Searches were performed with variable methionine oxidation, pyro-glutamic acid formation (from N-terminal glutamic acid and glutamine) and variable iodoacetamide and acrylamide modifications on cysteine or iTRAQ modifications, if appropriate. If the native data contained charge state information, it was used; when charge state information was not available, either +1 or both +2, +3 were searched. Consideration for potential ion pairs that might degrade MS analysis (that is, glutamic acid and aspartic acid residues in carboxylate form and ion-paired with Na + or K + ) revealed a negligible contribution, and these ion pairs were not included.
Validation of the search results was performed using the Trans Proteomic Pipeline (TPP) software suite 22 . The TPP tool Peptide-Prophet 31 modeled the correct and incorrect spectrum assignments, calculating a probability of being correct to each match based on the models. The ProteinProphet tool 32 was then used to adjust the identification probabilities based on corroborating evidence of other identifications that include tandem MS of similar matching characteristics but of lower quality within each dataset and, notably, perform a protein-inference step that coalesces the identifications that map to multiple proteins into single consensus identifications. This processing and validation produced a high-quality set of identifications for each lab. A final centralized processing of all PeptideProphet results through a single Protein-Prophet run yields a global picture of all proteins detected by the 27 labs in the mass spectrometry analyses.
